MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Organon & Co

Suletud

SektorTervishoid

10.25 -3.3

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.2

Max

10.76

Põhinäitajad

By Trading Economics

Sissetulek

-174M

-87M

Müük

81M

1.6B

P/E

Sektori keskmine

4.03

37.257

Aktsiakasum

1

Dividenditootlus

7.81

Kasumimarginaal

-5.443

Töötajad

10,000

EBITDA

124M

449M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+36.79% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

7.81%

2.94%

Järgmine tulemuste avaldamine

30. okt 2025

Järgmine dividendimakse kuupäev

11. dets 2025

Järgmine aktsia dividendi kuupäev (ex-date)

11. nov 2025

Turustatistika

By TradingEconomics

Turukapital

304M

2.8B

Eelmine avamishind

13.55

Eelmine sulgemishind

10.25

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Organon & Co Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. okt 2025, 20:45 UTC

Tulu

Costco Wholesale Sales Climb in September, Early October

8. okt 2025, 20:12 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

TaskUs Shares Fall After Holders Reject Take-Private Deal

8. okt 2025, 16:39 UTC

Suurimad hinnamuutused turgudel

Mining Shares Rise as Gold Prices Soar

8. okt 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. okt 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8. okt 2025, 23:18 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Finance Acquisition Using Internal Funds

8. okt 2025, 23:17 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8. okt 2025, 23:16 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8. okt 2025, 21:54 UTC

Market Talk
Tulu

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8. okt 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8. okt 2025, 21:26 UTC

Market Talk
Tulu

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. okt 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8. okt 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8. okt 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Will Remain a Publicly Traded Co >TASK

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8. okt 2025, 18:45 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8. okt 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8. okt 2025, 16:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Energy & Utilities Roundup: Market Talk

8. okt 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. okt 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. okt 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8. okt 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8. okt 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8. okt 2025, 15:44 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8. okt 2025, 15:44 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8. okt 2025, 15:43 UTC

Omandamised, ülevõtmised, äriostud

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8. okt 2025, 15:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Organon & Co Prognoos

Hinnasiht

By TipRanks

36.79% tõus

12 kuu keskmine prognoos

Keskmine 14.5 USD  36.79%

Kõrge 18 USD

Madal 11 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Organon & Co 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

8.53 / 9.18Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

No Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
help-icon Live chat